Home Activity Tracking in CMT1A Nerve Disease Patients
Part of Brain & nervous system, Genetic & congenital clinical trials.
This study watches how much you move around at home using a small wearable sensor if you have CMT1A, a genetic nerve condition that affects walking. Researchers want to understand daily activity patterns to better support patients with this condition.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have been genetically confirmed to have CMT1A (a specific genetic change called PMP22 duplication)
- You are able to walk on your own, with or without aids like canes or walkers
- You can wear a small sensor device on your skin without allergic reactions or discomfort
- You live in France and are enrolled in the French social security system
- You are not pregnant, breastfeeding, or under legal guardianship
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses motion analysis to understand walking and arm function in adults with certain neurological or metabolic diseases. The goal is to find patterns that help doctors better manage these conditions.
This study looks at how Charcot-Marie-Tooth disease (CMT) or related inherited nerve conditions change over time. It may help researchers better understand what to expect and guide future treatments.
This study observes how your arms and legs move as you walk or do other activities. It compares people with conditions that affect movement (like muscle diseases) to healthy volunteers to understand differences.
This study is looking for people with Charcot-Marie-Tooth disease (a nerve condition) and healthy volunteers to track long-term changes in the body. Researchers want to see if certain biomarkers (measurable signs) can help predict how CMT progresses over time.
This study looks at fatigue and how it affects walking and balance in people with Charcot-Marie-Tooth type 1A. By comparing results with healthy volunteers, researchers hope to better understand fatigue and find ways to help.
This trial looks for new markers of Charcot-Marie-Tooth 1A (CMT1A) early in the disease. Researchers hope to find signs that can help diagnose and track the disease better, which could lead to better treatments in the future.
Hear when a new Motor Activity trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.